Kylonib 150mg Capsule: Effective Relief for Your Needs

Kylonib 150mg Capsule

Description:

• Active ingredient: Nilotinib.
• Class: Antineoplastic drug, tyrosine kinase inhibitor.
• Use: Treats Philadelphia chromosome-positive chronic myeloid leukemia (Ph-positive CML), a blood cancer with abnormal production of white blood cells.
• Patient groups: Used in newly diagnosed adult and pediatric patients with CML, and in patients who have side effects from previous treatment or are no longer responding to other treatments like Imatinib.

Contraindications:

• Allergies: Do not take if allergic to Nilotinib or other ingredients.
• Heart conditions: Notify your doctor if you have or had heart conditions, chest pain, brain stroke, or claudication.
• Liver or pancreas disorders: Inform your doctor if you have liver or pancreas disorders.
• Potassium and magnesium levels: Inform your doctor if you have low potassium or magnesium levels.
• Grapefruit: Avoid consuming grapefruit or grapefruit juice.
• Sugar intolerance: Inform your doctor if you are intolerant to some sugar, as this medicine contains lactose.

Monitoring during treatment:

• Regular blood tests to monitor liver and pancreas function, blood cell counts (WBC, RBC, platelets), heart condition (QT interval), electrolytes, sugar, and fats.
• Inform your doctor if you are pregnant, planning to get pregnant, or breastfeeding.

Therapeutic effects:

• BCR-ABL tyrosine kinase is responsible for uncontrolled cell division in CML. Kylonib 150mg disrupts the signaling route of the protein kinase enzyme, targeting the BCR-ABL protein and inhibiting the growth and spread of cancer cells.

Interaction with other drugs:

• Inform your healthcare professional about all the medicines you take, including prescription, over-the-counter, nutritional and vitamin supplements, and herbal products.
• Certain medications may reduce effectiveness or cause undesirable side effects.

Safety advice:

• Pregnancy: Kylonib 150mg is unsafe to use during pregnancy unless necessary.
• Breastfeeding: Taking Kylonib 150mg while breastfeeding may be unsafe.
• Lungs: Consult your doctor if you have lung conditions.
• Liver: Inform your physician if you have liver problems.
• Alcohol: It is unknown whether consuming alcohol while taking a Kylonib 150mg capsule is safe.
• Driving: While taking Kylonib 150mg, it is unsafe to drive or use machines.

Side effects:

• Serious: Sudden weight gain, swelling in hands, feet, ankles, or face, chest pain, blood pressure changes, discoloration of tongue, lips, or skin (blue), abnormal heart (irregular heartbeat), hair loss, vision problems, stomach pain, vomiting of blood, blood in stools, yellowing of the skin, eyes, and dark urine, high blood sugar levels, sensitivity to light.
• Common: Nausea, vomiting, diarrhoea, headache, muscle pain, stomach pain, tiredness, constipation, slowing of growth in children, pneumonia, loss of appetite, sleeplessness, depression, anxiety, stomach discomforts like bloating and flatulence after meals, musculoskeletal pain.

FAQs:

• Q 1. Can Kylonib 150mg cause liver damage? Kylonib 150mg may cause liver function abnormalities, which may indicate liver damage. Regular blood tests are important to monitor liver function.
• Q 2. How does Kylonib 150mg differ from other medications used to treat chronic myeloid leukemia, such as Imatinib? Kylonib 150mg is more selective for the BCR-ABL protein and more potent in inhibiting its activity. It is effective in patients who have developed resistance to Imatinib.
• Q 3. What are the potential long-term effects of Kylonib 150mg on the body? Potential long-term effects include cardiovascular events, liver dysfunction, pancreatic enzyme elevation, and fluid retention. These side effects are generally rare.
• Q 4. How to monitor the effects of Kylonib 150mg over the course of treatment? Monitoring includes regular blood tests, electrocardiograms, and imaging studies.
• Q 5. Who should not take Kylonib 150mg? Kylonib 150mg should not be taken by pregnant or breastfeeding women, or by people with certain medical conditions such as severe liver or kidney disease, a history of pancreatitis, or a prolonged QT interval.

Fact box:

• Molecule name: Nilotinib.
• Therapeutic class: Antineoplastic drug.
• Pharmacological class: Tyrosine Kinase inhibitors.
• Indications: Blood cancer (Philadelphia chromosome-positive chronic myeloid leukemia) in adults and pediatrics.

Теги: kylonib, capsule, 150mg, medicine, health, pharmacy, drug, medication